{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T03:58:50Z","timestamp":1754193530798},"reference-count":22,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Psoriatic arthritis (PsA) is a chronic and debilitating disease that can be managed by different clinical specialists.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>The objective of the <jats:styled-content style=\"fixed-case\">LOOP<\/jats:styled-content> study was to evaluate the impact of clinical specialty setting on the time to diagnosis and treatment of patients with PsA. Clinical disease activity and disease burden were also compared between clinical settings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">LOOP<\/jats:styled-content> was a cross\u2010sectional, multicentre, observational study conducted in 17 countries in Western and Eastern Europe, the Middle East, Latin America and Asia. Adult patients (\u226518\u00a0years) with a suspected or established diagnosis of PsA who were routinely visiting a rheumatologist, dermatologist or non\u2010rheumatology\/non\u2010dermatology physician were enrolled. All patients were assessed by both a rheumatologist and a dermatologist.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 1483 enrolled patients, a total of 1273 had a confirmed diagnosis of PsA. There was no significant difference in the median time from onset of inflammatory musculoskeletal symptoms to PsA diagnosis between patients enrolled by rheumatologists and dermatologists (6.0 vs. 3.9\u00a0months). However, the median time from diagnosis to first treatment with a conventional synthetic disease\u2010modifying anti\u2010rheumatic drug (cs<jats:styled-content style=\"fixed-case\">DMARD<\/jats:styled-content>) was significantly shorter in the rheumatology setting compared with the dermatology setting (0 vs. 2.0\u00a0months; <jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.001). In addition, disease activity was significantly higher in the dermatology setting compared with the rheumatology setting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Differences in the management and clinical status of patients with PsA were observed between the rheumatology and dermatology settings. Importantly, median time from diagnosis to first cs<jats:styled-content style=\"fixed-case\">DMARD<\/jats:styled-content> was significantly shorter in the rheumatology setting, and patients in the dermatology setting had higher disease activity. These data show the importance of improved collaboration between rheumatologists and dermatologists.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jdv.16251","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T05:37:27Z","timestamp":1580449047000},"page":"2035-2043","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Association between clinical specialty setting and disease management in patients with psoriatic arthritis: results from <scp>LOOP<\/scp>, a cross\u2010sectional, multi\u2010country, observational study"],"prefix":"10.1111","volume":"34","author":[{"given":"W.H.","family":"Boehncke","sequence":"first","affiliation":[{"name":"Division of Dermatology and Venereology Geneva University Hospitals Geneva Switzerland"},{"name":"Department of Pathology and Immunology Faculty of Medicine University of Geneva Geneva Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Horv\u00e1th","sequence":"additional","affiliation":[{"name":"Department of Paediatric and Adult Rheumatology University Hospital Motol Prague Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Dalkili\u00e7","sequence":"additional","affiliation":[{"name":"Department of Rheumatology Uluda\u011f University School of Medicine Gorukle, Bursa Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.A.L.","family":"Lima","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Rheumatology ABC Medical School Santo Andr\u00e9 Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Okada","sequence":"additional","affiliation":[{"name":"Immuno\u2010Rheumatology Center St. Luke's International Hospital Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hojnik","sequence":"additional","affiliation":[{"name":"Formerly AbbVie Ljubljana Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ganz","sequence":"additional","affiliation":[{"name":"AbbVie AG Baar Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lubrano","sequence":"additional","affiliation":[{"name":"Department of Medicine and Health Sciences Vincenzo Tiberio University of Molise Campobasso Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,3,6]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.032482"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1505557"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30949-8"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(73)90035-8"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.150938"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204858"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202608"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208337"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23789"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39573"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21972"},{"issue":"10","key":"e_1_2_7_13_1","first-page":"123","article-title":"Etanercept and methotrexate as monotherapy or in combination in patients with psoriatic arthritis: a phase 3, double\u2010blind, randomized controlled study [abstract]","volume":"79","author":"Mease P","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60125-8"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810652"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314258"},{"key":"e_1_2_7_17_1","article-title":"A head\u2010to\u2010head comparison of the efficacy and safety of ixekizumab and adalimumab in biological\u2010naive patients with active psoriatic arthritis: 24\u2010week results of a randomised, open\u2010label, blinded\u2010assessor trial","author":"Mease PJ","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2017.29.1.48"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.07.023"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13700"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13210"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4238-4"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2014.01.004"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.16251","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.16251","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jdv.16251","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.16251","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T02:25:06Z","timestamp":1693707906000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.16251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,6]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1111\/jdv.16251"],"URL":"https:\/\/doi.org\/10.1111\/jdv.16251","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,6]]},"assertion":[{"value":"2019-05-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}